Validation of the Totaled Health Risks In Vascular Events (THRIVE) score for outcome prediction in endovascular stroke treatment

International Journal of Stroke

Volumn 9, Issue 1, 2014, Pages 32-39

  Flint, Alexander C ^a   Kamel, Hooman ^b   Rao, Vivek A ^a   Cullen, Sean P ^a   Faigeles, Bonnie S ^a   Smith, Wade S ^c  

^a Kaiser Permanente Redwood City ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute stroke therapy; Cerebral infarction; Hypertension; Intervention; Ischaemic stroke; Risk factors

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RECEIVER OPERATING CHARACTERISTIC; REGISTER; SCORING SYSTEM; TOTALED HEALTH RISKS IN VASCULAR EVENTS SCORE; TREATMENT OUTCOME;

ACUTE STROKE THERAPY; CEREBRAL INFARCTION; HYPERTENSION; INTERVENTION; ISCHAEMIC STROKE; RISK FACTORS;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; REGISTRIES; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; STROKE; TREATMENT OUTCOME;

EID: 84890807982     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00872.x     Document Type: Article

References (18)

1. Furlan A, Higashida R, Wechsler L etal. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282:2003-2011.
2. Smith WS, Sung G, Starkman S etal. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36:1432-1438.
3. Smith WS, Sung G, Saver J etal. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008; 39:1205-1212.
4. Flint AC, Duckwiler GR, Budzik RF, Liebeskind DS, Smith WS. Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Stroke 2007; 38:1274-1280.
5. The Penumba Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009; 40:2761-2768.
6. Brinjikji W, Rabinstein AA, Kallmes DF, Cloft HJ. Patient outcomes with endovascular embolectomy therapy for acute ischemic stroke: a study of the national inpatient sample: 2006 to 2008. Stroke 2011; 42:1648-1652.
7. Baker WL, Colby JA, Tongbram V etal. Neurothrombectomy devices for the treatment of acute ischemic stroke: state of the evidence. Ann Intern Med 2011; 154:243-252.
8. Nogueira RG, Liebeskind DS, Sung G, Duckwiler G, Smith WS. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI trials. Stroke 2009; 40:3777-3783.
9. Barreto AD, Albright KC, Hallevi H etal. Thrombus burden is associated with clinical outcome after intra-arterial therapy for acute ischemic stroke. Stroke 2008; 39:3231-3235.
10. Tessier A, Finch L, Daskalopoulou SS, Mayo NE. Validation of the Charlson Comorbidity Index for predicting functional outcome of stroke. Arch Phys Med Rehabil 2008; 89:1276-1283.
11. Rymer MM, Budzik RF, Devlin TG, Lutsep HL, Smith WS. Interventional acute stroke therapy with the Merci Retriever embolectomy device: results from 1000 patients in an open label prospective multicenter registry. In Late-Breaking Abstracts. Los Angeles, California, 2011. Available at http://my.americanheart.org/professional/Sessions/InternationalStrokeConference/ScienceNews/Late-Breaking-Abstracts_UCM_426023_Article.jsp (accessed 25 August 2011).
12. Flint AC, Cullen SP, Faigeles BS, Rao VA. Predicting long-term outcome after endovascular stroke treatment: the totaled health risks in vascular events score. AJNR Am J Neuroradiol 2010; 31:1192-1196.
13. Johnston SC, Rothwell PM, Nguyen-Huynh MN etal. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007; 369:283-292.
14. Merci Registry - real world use of the merci retrieval system in acute ischemic stroke. ClinicalTrials.gov Identifier NCT00478478. Available at http://clinicaltrials.gov/ct2/show/NCT00478478?term=NCT00478478&rank=1 (accessed 25 August 2011).
15. Merci Registry. Available at http://www.strokecenter.org/trials/TrialDetail.aspx?tid=758 (accessed 25 August 2011).
16. Clarke JL, Johnston SC, Farrant M, Bernstein R, Tong D, Hemphill JC 3rd. External validation of the ICH score. Neurocrit Care 2004; 1:53-60.
17. Grigoryan M, Tung CE, Albers GW. Role of diffusion and perfusion MRI in selecting patients for reperfusion therapies. Neuroimaging Clin N Am 2011; 21:247-257, ix-x.
18. Kiphuth IC, Köhrmann M, Kuramatsu JB etal. Retrospective agreement and consent to neurocritical care is influenced by functional outcome. Crit Care 2010; 14:R144.